Navigation Links
Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
Date:11/24/2008

esearcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has edited three books, and written four others, including the best-selling textbook, Essential Psychopharmacology, now in its third edition and the best-selling clinical manual, Essential Psychopharmacology Prescriber's Guide.

Dr. Sheehan has been a consultant to the World Health Organization, the World Federation of Societies of Biological Psychiatry, the International Academy for Biomedical and Drug Research, the US Food and Drug Administration, and a research grant reviewer for the National Institute for Mental Health (NIMH). Dr. Sheehan has been invited to give over 1600 lectures in 64 countries throughout the world on anxiety and mood disorders, psychopharmacology and biological psychiatry. He was elected as a member of the American College of Psychiatrists and is a Distinguished Fellow of the American Psychiatric Association.

    About Labopharm's Novel Trazodone Formulation and the Market for
    Antidepressants

One-half of patients being treated with antidepressants discontinue therapy within a year for reasons related to efficacy and/or tolerability, including delayed onset of therapeutic response, insomnia or sleep disturbance, agitation, exacerbation of anxiety, sexual dysfunction, weight gain and somnolence. Labopharm has developed a novel once-daily formulation of 150 mg and 300 mg of trazodone hydrochloride, a serotonin antagonist reuptake inhibitor (SARI), for the treatment of major depressive disorder (MDD) to address patient needs in the current depression landscape, providing an effective and convenient treatment option. In a Phase III placebo controlled study of patients with MDD, Labopharm's novel trazodone formulation demonstrated antidepressant efficacy, including rapid onset of therapeutic response, improved overall quality of sleep, a well tolerated adverse event profile, a very low rat
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Tucson-based company ... employer’s benefits package, or health and wellness program, called ... while providing an effective way for employees to use ... of the program, employees specify the amount of each ... , An employer benefits from offering a 401(play)™ plan ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, ... new sleep experience. The top of each luxurious resort bed ... , These expertly crafted, 100% Egyptian cotton white duvets and ... yet upon closer look, words are woven in the linens ... breathe. , Intentional breathing and visualization are keys ...
(Date:7/29/2014)... 2014 In his latest blog post at ... CEO Per Wickstrom has listed 6 ways to light the ... creativity and avoid complacency, but for some it’s a losing ... progressive and powerful ways to help employees get to the ... as a whole.” , According to Per Wickstrom, 6 ways ...
(Date:7/29/2014)... Battle Creek, MI (PRWEB) July 29, 2014 ... treatment program that gets clients off to a great start ... believe in, was a proud sponsor of the National Cherry ... City, MI. , The concert, which was co-sponsored by Miller ... Collective Soul take to the Pepsi Bay Side Music Stage ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
Breaking Medicine News(10 mins):Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... Meeting of the American Political Science Association (APSA) will ... Metro Toronto Convention Centre, the InterContinental Toronto Centre, and ... time in its history that the meeting has been ... is the world,s largest gathering of political scientists; almost ...
... , ... its outreach to its current and future patients by its recent launch of accounts ... ... 2009 -- KoolDocs.com, the web,s leading resource for online medical consultations, diagnoses, prescriptions, and ...
... SCHAUMBURG, Ill., Aug. 27 Sagent Pharmaceuticals, Inc., ... has launched fluconazole injection in premix bags. IMS Health estimates ... Sagent will begin marketing and shipping fluconazole bags immediately. , ... again exemplified in our new fluconazole offering, the most recent ...
... , DES PLAINES, Ill. and NEW YORK, ... an agreement with Pfizer Inc to develop a molecular diagnostic test ... presence of gene rearrangements. Pfizer has developed a novel investigational ... many cancers. To be eligible to receive Pfizer,s oral therapy, ...
... , PRINCETON, N.J., Aug. 27 ... rare form of hemophilia are coming together at educational summits ... the Center for Biomedical Continuing Education (CBCE). For the fifth ... families with expert healthcare professionals and fellow patients to address ...
... , , , ... ) today announced that it has launched its newly updated online ... and motivated to live a healthier lifestyle. The free and open-to-everyone ... and other resources that allow people to share their experiences and ...
Cached Medicine News:Health News:105th APSA Meeting, world's largest for the study of politics, will be in Toronto Sept. 3-6 2Health News:KoolDocs.com Increases Online Presence through Social Networking Premium Online Medical Consultation Service Now on Facebook, Twitter, and LinkedIn 2Health News:Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready-to-Use IV Bags 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 3Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 4Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 2Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 3Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 4Health News:Weight Watchers(R) Launches New Community on WeightWatchers.com 2Health News:Weight Watchers(R) Launches New Community on WeightWatchers.com 3
(Date:7/28/2014)... July 28, 2014  MiMedx Group, Inc. (NASDAQ: MDXG ... regenerative biomaterials and bioimplants processed from human amniotic membrane, announced ... Highlights include: , Revenue exceeds ... 2013 to $25.6 million , Quarter-over-quarter ... Care revenue increases 181% over Q2 2013 and 40% sequentially ...
(Date:7/28/2014)... 28 th , 2014 – Oncolab, the Boston ... is making its AACC debut (booth #4051) at this year,s ... serum-based in vitro immunoassay, has been run for over 60,000 ... fight against cancer recurrence. Photo - http://photos.prnewswire.com/prnh/20140728/130547 ... survivors in the US alone, the race is on to ...
(Date:7/28/2014)... 28, 2014  Serco Inc., a provider of ... has been awarded a re-compete contract to support ... its Deployable Medical Systems.  Serco will provide deployable ... provide world-class healthcare to meet warfighter and humanitarian ... globe. The five year contract has a one-year ...
Breaking Medicine Technology:MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2
... DIEGO, Nov. 8, 2010 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... three and nine months ended September 30, 2010. ... prudent cash management and reflected $29.3 million in cash at ... ADVENTRX.  "We recently submitted a New Drug Application to the ...
... 2010 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... the Company,s Board of Directors and Audit Committee, effective ... Officer and Chief Operating Officer of ShangPharma, will resign ...
Cached Medicine Technology:ADVENTRX Reports Third Quarter Financial Results 2ADVENTRX Reports Third Quarter Financial Results 3ADVENTRX Reports Third Quarter Financial Results 4ADVENTRX Reports Third Quarter Financial Results 5ADVENTRX Reports Third Quarter Financial Results 6ShangPharma Announces Appointment of Benson Tsang as a Member of the Board of Directors and Audit Committee 2
Disposable Lacrimal Dilators...
Fine & Medium Tapers....
Skin Tone External Eyelid Weights...
Contour Design Eyelid Implants....
Medicine Products: